|
Prometheus Presents New Clinical Insights Into Diagnosis of Crohn's Disease in Children from Analysis of PROMETHEUS(R) IBD Serology 7 Test Results.
PR Newswire
|
November 17, 2008
|
COPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group.
(Hide copyright information)
Copyright
|
Findings Presented at NASPGHAN-CDHNF Clinical and Scientific Conference
SAN DIEGO, Nov. 17 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, announced new findings regarding the correlation between serologic markers and the diagnostic predictions of children with Crohn's disease following an analysis of PROMETHEUS(R) IBD Serology 7 test results. Prometheus believes that PROMETHEUS IBD Serology 7 is the most comprehensive diagnostic test available to help physicians detect inflammatory bowel disease (IBD) and ...
Find more facts and information related to the
article "Prometheus Presents New Clinical Insights Into ..."